Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Part D PAPs inconsistent

Executive Summary

Availability and assistance from pharmaceutical assistance programs sponsored by states and drug makers are uneven, according to GAO. Its Sept. 5 report finds that only 23 states currently offer 37 qualified programs; eligibility and the type and extent of assistance vary between programs, with 20 programs offering broadly defined assistance, while 14 are aimed at a specific disease or condition. Manufacturer-sponsored PAPs also vary in eligibility requirements and application process, GAO notes, and are typically limited to the drugs that the manufacturer produces

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel